文献速递造血干细胞移植与细胞治疗淋巴瘤

异基因造血细胞移植后免疫介导结局的遗传关联

Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation.
PubMed 文献 · Blood Adv · 2022-01-01

在4270例欧洲血统异基因造血细胞移植受者中验证200余个候选基因变异,并在1827例同胞和1447例10/10 HLA相合无关供者亚组中分析。候选变异分析发现受者HLA-DPB1单核苷酸多态性与无关供者移植后aGVHD风险增加及复发风险降低相关;GWAS发现cGVHD与NHS基因X连锁内含子变异关联,但第二复制队列未确认。

要点

  • 受者HLA-DPB1单核苷酸多态性与无关供者移植后aGVHD风险增加和复发风险降低相关。
  • 该关联反映与HLA-DPB1表达水平的相关性,此前已显示影响无关受者aGVHD和复发风险。
  • GWAS发现cGVHD与NHS基因X连锁内含子变异关联,但第二复制队列未确认,未得出明确结论。

核心结论

  • 候选变异分析发现一组紧密连锁的受者HLA-DPB1单核苷酸多态性与无关供者移植后aGVHD风险增加及复发风险降低相关。
  • GWAS发现cGVHD与NHS基因X连锁内含子变异关联,但第二复制队列未确认,未就该发现的有效性得出明确结论。

研究设计与样本

  • 在4270例欧洲血统异基因造血细胞移植受者中验证既往发现的200余个与aGVHD、cGVHD或复发相关的候选供受者基因变异。
  • 在1827例同胞供者和1447例10/10 HLA-A、B、C、DRB1、DQB1相合无关供者的亚组中分析。
  • 对相同结局进行全基因组关联研究(GWAS)。
  • 候选变异采用发现和复制分析。

主要发现

  • 候选变异分析发现一组紧密连锁的受者HLA-DPB1单核苷酸多态性与无关供者移植后aGVHD风险增加及复发风险降低相关。
  • 上述结果反映与HLA-DPB1表达水平的相关性,此前已显示影响无关受者aGVHD和复发风险。
  • GWAS发现cGVHD与NHS基因X连锁内含子变异关联,NHS基因调节肌动蛋白重塑和细胞形态。
  • 在第二复制队列中评估该关联未确认原始复制结果。

局限性

  • 本研究队列大于多数既往HCT研究,但小于其他基因型-表型关联研究通常使用的队列。
  • 第二复制队列未确认NHS基因变异与cGVHD的关联,未就该发现的有效性得出明确结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Previous studies have identified more than 200 genetic variants associated with acute or chronic graft-versus-host disease (aGVHD; cGVHD) or recurrent malignancy after allogeneic hematopoietic cell transplantation (HCT). We tested these candidate donor and recipient variants in a cohort of 4270 HCT recipients of European ancestry and in subcohorts of 1827 sibling and 1447 unrelated recipients who had 10/10 HLA-A, B, C, DRB1, and DQB1-matched donors. We also carried out a genome-wide association study (GWAS) for these same outcomes. The discovery and replication analysis of candidate variants identified a group of closely linked recipient HLA-DPB1 single-nucleotide polymorphisms (SNPs) associated with an increased risk of aGVHD and a corresponding decreased risk of recurrent malignancy after unrelated HCT. These results reflect a correlation with the level of HLA-DPB1 expression previously shown to affect the risks of aGVHD and relapse in unrelated recipients. Our GWAS identified an association of cGVHD with a locus of X-linked recipient intron variants in NHS, a gene that regulates actin remodeling and cell morphology. Evaluation of this association in a second replication cohort did not confirm the original replication results, and we did not reach any definitive conclusion regarding the validity of this discovery. The cohort used for our study is larger than those used in most previous HCT studies but is smaller than those typically used for other genotype-phenotype association studies. Genomic and disease data from our study are available for further analysis in combination with data from other cohorts.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Martin PJ, Levine DM, Storer BE, et al. Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation. Blood Adv. 2022. PMID: 34996099. doi:10.1182/bloodadvances.2021005620

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。